ENTA icon

Enanta Pharmaceuticals

107 hedge funds and large institutions have $114M invested in Enanta Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less ownership

Funds ownership:

11% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 27

21% less call options, than puts

Call options by funds: $56K | Put options by funds: $71K

48% less capital invested

Capital invested by funds: $220M → $114M (-$105M)

Holders
107
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$56K
Puts
$71K
Net Calls
Net Calls Change

Top Buyers

1 +$5.97M
2 +$3.56M
3 +$1.91M
4
Millennium Management
Millennium Management
New York
+$953K
5
BlackRock
BlackRock
New York
+$801K

Top Sellers

1 -$10.4M
2 -$8.14M
3 -$4.03M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.96M
5
Ameriprise
Ameriprise
Minnesota
-$1.48M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$12.2M
2
$12.1M
3
$11.7M
4
$11.4M
5
$7.02M
6
$5.97M
7
$5.35M
8
$5.16M
9
$4.88M
10
$2.86M
11
$2.74M
12
$2.65M
13
$2.42M
14
$2.23M
15
$1.91M
16
$1.71M
17
$1.67M
18
$1.11M
19
$1.06M
20
$1.02M
21
$938K
22
$930K
23
$918K
24
$910K
25
$899K